Radiomics and radiogenomics of prostate cancer.

Genomics Humans Male Prostatic Neoplasms / diagnostic imaging
Imaging Prostate cancer Radiogenomics Radiomics

Journal

Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 22 6 2018
medline: 8 8 2020
entrez: 22 6 2018
Statut: ppublish

Résumé

Radiomics and radiogenomics are attractive research topics in prostate cancer. Radiomics mainly focuses on extraction of quantitative information from medical imaging, whereas radiogenomics aims to correlate these imaging features to genomic data. The purpose of this review is to provide a brief overview summarizing recent progress in the application of radiomics-based approaches in prostate cancer and to discuss the potential role of radiogenomics in prostate cancer.

Identifiants

DOI: 10.1007/s00261-018-1660-7 PMID: 29926137
pubmed: 29926137
doi: 10.1007/s00261-018-1660-7
pii: 10.1007/s00261-018-1660-7
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2021-2029

Subventions

Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States

Auteurs

Clayton P Smith (CP)

Molecular Imaging Program, National Cancer Institute, NIH, 10 Center drive, room B3B85, Bethesda, MD, 20892, USA.
Georgetown University School of Medicine, Washington, DC, USA.

Marcin Czarniecki (M)

Molecular Imaging Program, National Cancer Institute, NIH, 10 Center drive, room B3B85, Bethesda, MD, 20892, USA.

Sherif Mehralivand (S)

Molecular Imaging Program, National Cancer Institute, NIH, 10 Center drive, room B3B85, Bethesda, MD, 20892, USA.
Urologic Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA.
Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany.

Radka Stoyanova (R)

Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, USA.

Peter L Choyke (PL)

Molecular Imaging Program, National Cancer Institute, NIH, 10 Center drive, room B3B85, Bethesda, MD, 20892, USA.

Stephanie Harmon (S)

Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc, NCI Campus at Frederick, Frederick, MD, USA.

Baris Turkbey (B)

Molecular Imaging Program, National Cancer Institute, NIH, 10 Center drive, room B3B85, Bethesda, MD, 20892, USA. turkbeyi@mail.nih.gov.
ORCID: 0000-0003-0853-6494

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Disciplines des sciences naturelles › Disciplines des sciences biologiques › Biologie › Génétique › Génomique › Radiomics and radiogenomics of prostate cancer.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Radiomics and radiogenomics of prostate cancer.
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital mâle › Tumeurs de la prostate › Radiomics and radiogenomics of prostate cancer.